Mealey's (July 11, 2022, 1:03 PM EDT) -- WASHINGTON, D.C. — A District of Columbia Circuit U.S. Court of Appeals panel on July 7 granted a joint motion by Juul Labs Inc. (JLI) and the Food and Drug Administration to hold in abeyance JLI’s petition for review of the FDA’s recent marketing denial order (MDO) prohibiting sales and distribution of all JLI e-cigarette products, a day after the parties informed the court that the FDA’s tobacco office decided JLI’s products present “scientific issues . . . that warrant additional review.”...